538 research outputs found
The ongoing dissection of the genetic architecture of autistic spectrum disorder
The development of robust, non-hypothesis based case/control studies has led to a large push forward towards identifying common genetic variants that contribute to complex traits. However, despite many attempts, the search for common disease-predisposing variants in childhood developmental disorders has largely failed. Recently, a role for rare causal variants and de novo mutations is emerging in the genetic architecture of some of these disorders, particularly those that incur a large degree of selection against the phenotype. In this paper, we examine these data and use classic genetic epidemiological approaches to gain insights into the genetic architecture of ASD. Future studies using next generation sequencing should elucidate the precise role de novo mutations play in disorders traditionally thought to have resulted from polygenic or common disease, common variants inheritance
Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms
Research aimed at understanding amyotrophic lateral sclerosis (ALS) has seen exceptional growth in the past few years. New genes, new models, and new mechanisms have not only improved our understanding, but also contributed to the increasing complexity of ALS pathogenesis. The focus of this piece is to highlight some of the more notable developments in the field and to encourage a re-appreciation for the superoxide dismutase 1 (SOD1) mouse models
Congenital mirror movements in a new Italian family
Mirror movements (MMs) occur on the contralateral side of a limb being used intentionally.
Because few families with congenital MMs and no other neurological signs have been reported, the underlying
mechanisms of MMs are still not entirely clear. We report on the clinical, genetic, neurophysiological and
neuroimaging findings of 10 of 26 living members of a novel four-generation family with congenital MMs. DCC
and RAD51 were sequenced in affected members of the family. Five of the ten subjects with MMs underwent
neurophysiological and neuroimaging evaluations. The neurophysiological evaluation consisted of
electromyographic (EMG) mirror recordings, investigations of corticospinal excitability, and analysis of
interhemispheric inhibition using transcranial magnetic stimulation techniques. The neuroimaging evaluation
included functional MRI during finger movements. Eight (all females) of the ten members examined presented
MMs of varying degrees at the clinical assessment. Transmission of MMs appears to have occurred according
to an autosomal-dominant fashion with variable expression. No mutation in DCC or RAD51 was identified. EMG
mirror activity was higher in MM subjects than in healthy controls. Short-latency interhemispheric inhibition
was reduced in MM subjects. Ipsilateral motor-evoked potentials were detectable in the most severe case.
The neuroimaging evaluation did not disclose any significant abnormalities in MM subjects. The variability of
the clinical features of this family, and the lack of known genetic abnormalities, suggests that MMs are
heterogeneous disorders. The pathophysiological mechanisms of MMs include abnormalities of transcallosal
inhibition and corticospinal decussatio
Characterization of Sirtuin Inhibitors in Nematodes Expressing a Muscular Dystrophy Protein Reveals Muscle Cell and Behavioral Protection by Specific Sirtinol Analogues
n/
Sensory and motor neuronopathy in a patient with the A382P TDP-43 mutation
Patients with TARDBP mutations have so far been classified as ALS, sometimes with frontal lobe dysfunction. A 66-year-old patient progressively developed a severe sensory disorder, followed by a motor disorder, which evolved over nine years. Symptoms started in the left hand and slowly involved the four limbs. Investigations were consistent with a mixed sensory and motor neuronopathy. A heterozygous change from an alanine to a proline at amino acid 382 was identified in exon 6 of the TARDPB gene (p.A382P). This case expands the phenotypic spectrum associated with mutations in the TARDBP gene and shows that sensory neurons can be severely damaged early in the course of the disease, following a propagating process, with an orderly progression from a focal starting point. A combination of severe sensory and motor neuronopathy is rarely encountered in clinical practice. The possibility of an A382P TDP-43 mutation should be considered in patients with such an association
A novel PLP1 mutation further expands the clinical heterogeneity at the locus
Objectives: To characterize at clinical and molecular levels a family presenting with X-linked recessive Hereditary Spastic Paraplegia (HSP). Background: HSPs are a large group of genetically heterogeneous neurodegenerative disorders characterized by progressive upper motor neuron signs. Mutations in the proteolipid protein (PLP1) gene have been identified in families linked to the SPG2 locus on chromosome Xq22. However, Pelizaeus-Merzbacher disease (PMD) is also an X-linked recessive neurological disorder caused by PLP1 mutations. Methods: The SPG2 locus was investigated by linkage analysis in the family. The PLP1 gene was screened by sequencing. We present findings in a large French-Canadian family with an X-linked recessive HSP. The proband presented early with developmental delay and developed progressive spastic paraplegia. He has been wheelchair-bound since the age of three years. At the latest follow-up, he was 20 years-old and had severe spasticity predominantly affecting the lower extremities, moderate cerebellar dysfunction, and optic atrophy. Results: Linkage to SPG2 was established and a G to A mutation (MIR) in the initiation codon of the PLP1 gene was identified, likely resulting in the complete absence of proteolipid protein. Conclusions: We report a new PLP1 gene mutation in a patient with a clinical phenotype consistent with a PLP1 null syndrome
A direct interaction between two Restless Legs Syndrome predisposing genes : MEIS1 and SKOR1
Restless Legs syndrome (RLS) is a common sleep disorder for which the genetic contribution remains
poorly explained. In 2007, the frst large scale genome wide association study (GWAS) identifed three
genomic regions associated with RLS. MEIS1, BTBD9 and MAP2K5/SKOR1 are the only known genes
located within these loci and their association with RLS was subsequently confrmed in a number of
follow up GWAS. Following this fnding, our group reported the MEIS1 risk haplotype to be associated
with its decreased expression at the mRNA and protein levels. Here we report the efect of the risk
variants of the three other genes strongly associated with RLS. While these variants had no efect on
the mRNA levels of the genes harboring them, we fnd that the homeobox transcription factor MEIS1
positively regulates the expression of the transcription co-repressor SKOR1. This regulation appears
mediated through the binding of MEIS1 at two specifc sites located in the SKOR1 promoter region
and is modifed by an RLS associated SNP in the promoter region of the gene. Our fndings directly link
MEIS1 and SKOR1, two signifcantly associated genes with RLS and also prioritize SKOR1 over MAP2K5
in the RLS associated intergenic region of MAP2K5/SKOR1 found by GWAS
- …